Most cases of squamous cell carcinoma can be cured when found early and treated ... The approach involves a surgeon removing skin tissue layer by layer, mapping and freezing each layer, and examining ...

These lesions are also sometimes known as cervical dysplasias or cervical intraepithelial neoplasia (CIN), High-grade ...

is the most common type of skin cancer. It starts in the top layer of the skin in cells called basal cells. Squamous cell carcinoma (SCC) is the second most common form of skin cancer. It starts ...

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

The following is a summary of “Oncologic outcomes for invasive squamous cell carcinoma with a clinically resolved biopsy site ...

James Martin was diagnosed with facial skin cancer in 2018 after spotting the first signs of the disease on his face ...

Basal cell carcinoma arises in sun-exposed skin, implying that actinic damage ... There is marked squamous dysplasia without invasion beyond the basement membrane. Lipid or immunohistochemical ...

Investigators sought to determine the safety and accuracy of remote cutaneous confocal microscopy vs histopathological diagnosis of melanoma and keratinocyte carcinoma.

Unloxcyt was approved by the FDA as a new treatment for patients with locally advanced or metastatic cutaneous squamous cell ...

The US Food and Drug Administration (FDA) has approved Unloxcyt (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are ...